E-LIB Suche - Ergebnisse für: Rewerska, Barbara

1

Phase 2b randomized trial of OX40 inhibitor telazorlimab fo..:

Rewerska, Barbara ; Sher, Lawrence D. ; Alpizar, Sady...
Journal of Allergy and Clinical Immunology: Global. 3 (2024) 1 - p. 100195 , 2024

Link: https://doi.org/10.1016/..

2

Efficacy and safety of baricitinib in combination with topi..:

Torrelo, Antonio ; Rewerska, Barbara ; Galimberti, Maria...
British Journal of Dermatology. 189 (2023) 1 - p. 23-32 , 2023

Link: https://doi.org/10.1093/..

3

Genome-wide association study of eosinophilic granulomatosi..:

Lyons, Paul A ; Peters, James E ; Alberici, Federico...
Nature Communications. 10 (2019) 1 - p. , 2019

Link: https://doi.org/10.1038/..

4

SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study..:

File Jr, Thomas M. ; Rewerska, Barbara ; Vucinić-Mihailović, Violeta...
Clinical Infectious Diseases. 63 (2016) 8 - p. 1007-1016 , 2016

Link: https://doi.org/10.1093/..

5

SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study..:

File Jr, Thomas M. ; Rewerska, Barbara ; Vucinić-Mihailović, Violeta...
Clinical Infectious Diseases. 63 (2016) 8 - p. 1007-1016 , 2016

Link: https://www.jstor.org/st..

6

Dual endothelin antagonist aprocitentan for resistant hyper..:

Schlaich, Markus ; Bellet, Marc ; Weber, Michael...
info:eu-repo/semantics/altIdentifier/doi/10.1016/S0140-6736(22)02034-7. , 2022

Link: https://hal.science/hal-..

7

Dual endothelin antagonist aprocitentan for resistant hyper..:

Schlaich, Markus ; Bellet, Marc ; Weber, Michael...
info:eu-repo/semantics/altIdentifier/doi/10.1016/S0140-6736(22)02034-7. , 2022

Link: https://hal.science/hal-..

8

Dual endothelin antagonist aprocitentan for resistant hyper..:

Schlaich, Markus ; Bellet, Marc ; Weber, Michael...
info:eu-repo/semantics/altIdentifier/doi/10.1016/S0140-6736(22)02034-7. , 2022

Link: https://hal.science/hal-..

9

Prognostic value of preoperative electrocardiography in pre..:

Studzińska, Dorota ; Polok, Kamil ; Rewerska, Barbara...
https://journals.viamedica.pl/kardiologia_polska/article/downloadSuppFile/89278/335602. , 2022

Link: https://journals.viamedi..

10

Dual endothelin antagonist aprocitentan for resistant hyper..:

Schlaich, Markus ; Bellet, Marc ; Weber, Michael...
info:eu-repo/semantics/altIdentifier/doi/10.1016/S0140-6736(22)02034-7. , 2022

Link: https://hal.science/hal-..

11

Dual endothelin antagonist aprocitentan for resistant hyper..:

Schlaich, Markus ; Bellet, Marc ; Weber, Michael...
info:eu-repo/semantics/altIdentifier/doi/10.1016/S0140-6736(22)02034-7. , 2022

Link: https://hal.science/hal-..

12

Dual endothelin antagonist aprocitentan for resistant hyper..:

Schlaich, Markus ; Bellet, Marc ; Weber, Michael...
info:eu-repo/semantics/altIdentifier/doi/10.1016/S0140-6736(22)02034-7. , 2022

Link: https://hal.science/hal-..

13

Genome-wide association study of eosinophilic granulomatosi..:

Lyons, Paul A ; Peters, James E ; Alberici, Federico...
doi:10.17863/CAM.59878. , 2020

Link: https://doi.org/10.17863..

14

Genome-wide association study of eosinophilic granulomatosi..:

Lyons, Paul A ; Peters, James E ; Alberici, Federico...
info:eu-repo/semantics/altIdentifier/pmid/31719529. , 2019

Link: http://hdl.handle.net/24..

15

Genome-wide association study of eosinophilic granulomatosi..:

Lyons, Paul A ; Peters, James E ; Alberici, Federico...
https://eprints.gla.ac.uk/199191/7/199191.pdf. , 2019

Link: https://eprints.gla.ac.u..